Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Neutralase heparinase I enzyme: IBT suspended enrollment of patients in its Phase III trial

IBT said that some additional bleeding was expected for the Neutralase group but

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE